G-Lasta subcutaneous injection 3.6mg by Kyowa Kirin contains Filgrastim (genetical recombination) [filgrastim follow-on 2]. This sustained-duration G-CSF product, YJ code 3399410G1020, is administered as 3.6mg in 0.36mL per tube to reduce the incidence of febrile neutropenia in patients undergoing cancer chemotherapy.
G-Lasta subcutaneous injection 3.6mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →